-
Je něco špatně v tomto záznamu ?
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood
T. Svobodova, E. Mejstrikova, U. Salzer, M. Sukova, P. Hubacek, R. Matej, M. Vasakova, L. Hornofova, M. Dvorakova, E. Fronkova, F. Votava, T. Freiberger, P. Pohunek, J. Stary, A. Janda,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem
Grantová podpora
NT14534
MZ0
CEP - Centrální evidence projektů
NLK
BioMedCentral
od 2001-12-01
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-09-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- B-lymfocyty imunologie MeSH
- infekce virem Epsteina-Barrové genetika imunologie MeSH
- intersticiální plicní nemoci diagnóza genetika imunologie MeSH
- leukopenie genetika imunologie MeSH
- lidé MeSH
- lymfopenie genetika imunologie MeSH
- mladiství MeSH
- monocyty imunologie MeSH
- mutace MeSH
- plíce patologie radiografie MeSH
- syndrom MeSH
- transkripční faktor GATA2 nedostatek genetika imunologie MeSH
- vaskulitida diagnóza genetika imunologie MeSH
- Check Tag
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
BACKGROUND: GATA-2 transcription factor deficiency has recently been described in patients with a propensity towards myeloid malignancy associated with other highly variable phenotypic features: chronic leukocytopenias (dendritic cell-, monocyto-, granulocyto-, lymphocytopenia), increased susceptibility to infections, lymphatic vasculature abnormalities, and sensorineural deafness. Patients often suffer from opportunistic respiratory infections; chronic pulmonary changes have been found in advanced disease. CASE PRESENTATION: We present a case of a 17-year-old previously healthy Caucasian male who was admitted to the hospital with fever, malaise, headache, cough and dyspnea. A chest X-ray revealed bilateral interstitial infiltrates and pneumonia was diagnosed. Despite prompt clinical improvement under antibiotic therapy, interstitial changes remained stable. A high resolution computer tomography showed severe diffuse parenchymal lung disease, while the patient's pulmonary function tests were normal and he was asymptomatic. Lung tissue biopsy revealed chronic reparative and resorptive reaction with organizing vasculitis. At the time of the initial presentation to the hospital, serological signs of acute infection with Epstein-Barr virus (EBV) were present; EBV viremia with atypical serological response persisted during two-year follow up. No other infectious agents were found. Marked monocytopenia combined with B-cell lymphopenia led to a suspicion of GATA-2 deficiency. Diagnosis was confirmed by detection of the previously published heterozygous mutation in GATA2 (c.1081 C > T, p.R361C). The patient's brother and father were both carriers of the same genetic defect. The brother had no clinically relevant ailments despite leukocyte changes similar to the index patient. The father suffered from spondylarthritis, and apart from B-cell lymphopenia, no other changes within the leukocyte pool were seen. CONCLUSION: We conclude that a diagnosis of GATA-2 deficiency should be considered in all patients with diffuse parenchymal lung disease presenting together with leukocytopenia, namely monocyto-, dendritic cell- and B-lymphopenia, irrespective of severity of the clinical phenotype. Genetic counseling and screening for GATA2 mutations within the patient's family should be provided as the phenotype is highly variable and carriers without apparent immunodeficiency are still in danger of developing myeloid malignancy. A prompt recognition of this rare condition helps to direct clinical treatment strategies and follow-up procedures.
Department of Pathology and Molecular Medicine Thomayer's University Hospital Prague Czech Republic
Department of Respiratory Medicine Thomayer's University Hospital Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16028455
- 003
- CZ-PrNML
- 005
- 20190828111016.0
- 007
- ta
- 008
- 161005s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12890-015-0006-2 $2 doi
- 024 7_
- $a 10.1186/s12890-015-0006-2 $2 doi
- 035 __
- $a (PubMed)25879889
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Svobodová, Tamara, $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. tamara.svobodova@lfmotol.cuni.cz. $d 1955- $7 mzk2007401084
- 245 10
- $a Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood / $c T. Svobodova, E. Mejstrikova, U. Salzer, M. Sukova, P. Hubacek, R. Matej, M. Vasakova, L. Hornofova, M. Dvorakova, E. Fronkova, F. Votava, T. Freiberger, P. Pohunek, J. Stary, A. Janda,
- 520 9_
- $a BACKGROUND: GATA-2 transcription factor deficiency has recently been described in patients with a propensity towards myeloid malignancy associated with other highly variable phenotypic features: chronic leukocytopenias (dendritic cell-, monocyto-, granulocyto-, lymphocytopenia), increased susceptibility to infections, lymphatic vasculature abnormalities, and sensorineural deafness. Patients often suffer from opportunistic respiratory infections; chronic pulmonary changes have been found in advanced disease. CASE PRESENTATION: We present a case of a 17-year-old previously healthy Caucasian male who was admitted to the hospital with fever, malaise, headache, cough and dyspnea. A chest X-ray revealed bilateral interstitial infiltrates and pneumonia was diagnosed. Despite prompt clinical improvement under antibiotic therapy, interstitial changes remained stable. A high resolution computer tomography showed severe diffuse parenchymal lung disease, while the patient's pulmonary function tests were normal and he was asymptomatic. Lung tissue biopsy revealed chronic reparative and resorptive reaction with organizing vasculitis. At the time of the initial presentation to the hospital, serological signs of acute infection with Epstein-Barr virus (EBV) were present; EBV viremia with atypical serological response persisted during two-year follow up. No other infectious agents were found. Marked monocytopenia combined with B-cell lymphopenia led to a suspicion of GATA-2 deficiency. Diagnosis was confirmed by detection of the previously published heterozygous mutation in GATA2 (c.1081 C > T, p.R361C). The patient's brother and father were both carriers of the same genetic defect. The brother had no clinically relevant ailments despite leukocyte changes similar to the index patient. The father suffered from spondylarthritis, and apart from B-cell lymphopenia, no other changes within the leukocyte pool were seen. CONCLUSION: We conclude that a diagnosis of GATA-2 deficiency should be considered in all patients with diffuse parenchymal lung disease presenting together with leukocytopenia, namely monocyto-, dendritic cell- and B-lymphopenia, irrespective of severity of the clinical phenotype. Genetic counseling and screening for GATA2 mutations within the patient's family should be provided as the phenotype is highly variable and carriers without apparent immunodeficiency are still in danger of developing myeloid malignancy. A prompt recognition of this rare condition helps to direct clinical treatment strategies and follow-up procedures.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a B-lymfocyty $x imunologie $7 D001402
- 650 _2
- $a infekce virem Epsteina-Barrové $x genetika $x imunologie $7 D020031
- 650 _2
- $a transkripční faktor GATA2 $x nedostatek $x genetika $x imunologie $7 D050989
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leukopenie $x genetika $x imunologie $7 D007970
- 650 _2
- $a plíce $x patologie $x radiografie $7 D008168
- 650 _2
- $a intersticiální plicní nemoci $x diagnóza $x genetika $x imunologie $7 D017563
- 650 _2
- $a lymfopenie $x genetika $x imunologie $7 D008231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a monocyty $x imunologie $7 D009000
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a syndrom $7 D013577
- 650 _2
- $a vaskulitida $x diagnóza $x genetika $x imunologie $7 D014657
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mejstříková, Ester, $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. ester.mejstrikova@lfmotol.cuni.cz. $d 1977- $7 xx0105223
- 700 1_
- $a Salzer, Ulrich $u Center for Chronic Immunodeficiency (CCI), University Medical Center and University of Freiburg, Freiburg im Breisgau, Germany. ulrich.salzer@uniklinik-freiburg.de.
- 700 1_
- $a Suková, Martina $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. martina.sukova@fnmotol.cz. $7 xx0128868
- 700 1_
- $a Hubáček, Petr, $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. petr.hubacek@lfmotol.cuni.cz. Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. petr.hubacek@lfmotol.cuni.cz. $d 1978- $7 xx0075829
- 700 1_
- $a Matěj, Radoslav, $u Department of Pathology and Molecular Medicine, Thomayer's University Hospital, Prague, Czech Republic. radoslav.matej@ftn.cz. $d 1974- $7 xx0103860
- 700 1_
- $a Koziar Vašáková, Martina, $u Department of Respiratory Medicine, Thomayer's University Hospital, Prague, Czech Republic. martina.vasakova@ftn.cz. $d 1964- $7 xx0104496
- 700 1_
- $a Hornofová, Ludmila $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. hornofova@centrum.cz. $7 xx0248458
- 700 1_
- $a Dvořáková, Marcela $u Department of Radiology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. marcela.dvorakova@fnmotol.cz. $7 xx0237805
- 700 1_
- $a Froňková, Eva, $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. eva.fronkova@lfmotol.cuni.cz. $d 1977- $7 xx0105058
- 700 1_
- $a Votava, Felix, $u Department of Pediatrics, 3rd Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic. felix.votava@fnkv.cz. $d 1957- $7 xx0060357
- 700 1_
- $a Freiberger, Tomáš $u Molecular Genetics Lab, Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic. tomas.freiberger@cktch.cz. Department of Clinical Immunology and Allergology, Medical Faculty, Masaryk University Brno, Brno, Czech Republic. tomas.freiberger@cktch.cz. $7 xx0071641
- 700 1_
- $a Pohunek, Petr, $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. petr.pohunek@lfmotol.cuni.cz. $d 1956- $7 jn99240000886
- 700 1_
- $a Starý, Jan, $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. jan.stary@lfmotol.cuni.cz. $d 1952- $7 jn19990009994
- 700 1_
- $a Janda, Ales $u Center for Chronic Immunodeficiency (CCI), University Medical Center and University of Freiburg, Freiburg im Breisgau, Germany. ales.janda@uniklinik-freiburg.de. Department of Pediatric Infectious Diseases and Rheumatology, Center of Pediatrics and Adolescent Medicine, University Medical Center and University of Freiburg, Mathildenstrasse 1, 79106, Freiburg im Breisgau, Germany. ales.janda@uniklinik-freiburg.de.
- 773 0_
- $w MED00008206 $t BMC pulmonary medicine $x 1471-2466 $g Roč. 15, č. - (2015), s. 8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25879889 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20190828111238 $b ABA008
- 999 __
- $a ok $b bmc $g 1166769 $s 953085
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 15 $c - $d 8 $e 20150210 $i 1471-2466 $m BMC pulmonary medicine $n BMC Pulm Med $x MED00008206
- GRA __
- $a NT14534 $p MZ0
- LZP __
- $a Pubmed-20161005